Also known as: PPB
Pharmacy and Poisons Board — Kenyan medicines regulator overseeing product safety, compliance inspections, and licensing of pharmaceutical professionals and premises.
Verbatim sentences from the source article.
Citizen Digital
… The Kenya Bureau of Standards (KEBS) is responsible for standards and conformity assessment for products entering the Kenyan market, while the Pharmacy and Poisons Board (PPB) regulates health products and technologies within its mandate. …
‘Clodigte’, ‘Senodcseoly’: Questions mount over suspected counterfeit toothpaste in KenyaThe Standard
… Days after recent revelations on expired HIV drugs and fake medications in public hospital stores, the Pharmacy and Poisons Board has issued fresh alerts regarding counterfeit Postinor-2 emergency contraceptives. …
Stem inflow of counterfeit medicinesThe Standard
Pharmacy and Poisons Board CEO Ahmed Mohammed, during an interview in Nairobi on August 17, 2026. …
Kenya tightens war on fake drugs with a medicine tracking systemCitizen Digital
… Audio By Vocalize The Pharmacy and Poisons Board (PPB) has approved seven new semaglutide-based medicines in Kenya, expanding treatment options for people living with type 2 diabetes as demand for the drugs continues to rise. …
Ozempic, Wegovy get new rivals as Kenya approves seven Semaglutide drugsThe Standard
… The Pharmacy and Poisons Board (PPB) raised the alarm after identifying falsified Postinor-2 (Levonorgestrel 0.75mg tablets), warning that the medicine may contain incorrect amounts of the active ingredient, no active ingredient at all, harmful contaminants or undeclared substanc …
Kenyans warned over fake morning-after pillsCitizen Digital
Pharmacy and Poisons Board issues alert on circulation of 'fake' P2 pills in Kenya By Kenneth Gachie August 14, 2026 11:03 (EAT) Add as a Preferred Source on Google Follow us Follow on Whatsapp Follow on Google Follow on Twitter A photo of a box containing P2 pills. …
Pharmacy and Poisons Board issues alert on circulation of 'fake' P2 emergency contraceptive pills in KenyaThe Standard
Audio By VocalizeThe Pharmacy and Poisons Board has warned the public against a fake batch of Postinor-2 (P2) tablets circulating in the Kenyan market. …
Pharmacy Board warns of fake P2 circulating in KenyaCitizen Digital
… In Kenya, this responsibility is entrusted to the Pharmacy and Poisons Board, the national medicines regulatory authority established under the Pharmacy and Poisons Act (Cap. …
OPINION: Why Medicines Regulation is Everyone’s BusinessCitizen Digital
… In Kenya, this responsibility is entrusted to the Pharmacy and Poisons Board, the national medicines regulatory authority established under the Pharmacy and Poisons Act (Cap. …
OPINION: Why Medicines Regulation is Everyone’s BusinessCitizen Digital
… He noted that the Pharmacy and Poisons Board (PPB) has the mandate to regulate all medical products and ensure they meet the highest standards of safety, quality and efficacy. …
CS Duale announces plan to ban antibiotics delivery by boda boda ridersThe Pharmacy and Poisons Board is strengthening Kenya's medicines regulatory systems to ensure medical products are safe, effective and of assured quality, with enhanced oversight across the life cycle of medical products including inspections of manufacturers and wholesalers.
30 September 2026 · The Standard →
The Pharmacy and Poisons Board is strengthening Kenya's medicines regulatory systems to ensure medical products are safe, effective and of assured quality, with enhanced oversight across the life cycle of medical products including inspections of manufacturers and wholesalers.
30 September 2026 · The Standard →
Mission for Essential Drugs and Supplies (MEDS) has launched MEDS Devane Company Limited (MDCL), a commercial enterprise to supply private hospitals, clinics, pharmacies and other healthcare institutions with medicines, medical consumables, diagnostics and equipment, beginning operations on November 1 with an initial focus on Kenya before expanding to East Africa.
30 September 2026 · The Standard →
Kenya aims to manufacture at least half of its essential health products locally by 2030 to reduce import dependence and establish itself as a regional pharmaceutical manufacturing hub. Health Cabinet Secretary Aden Duale said the strategy, part of the 2026–2030 Health Products and Technologies Local Manufacturing Strategy, will strengthen domestic production while improving access to quality and affordable medicines.
29 September 2026 · The Standard →
Kenya is targeting local production of at least half its essential health products by 2030 under a new 2026–2030 Health Products and Technologies Local Manufacturing Strategy, aimed at reducing reliance on imports and strengthening pharmaceutical security. The government has said 13 new pharmaceutical companies have commenced operations in Kenya, with some already producing medicines and other health products for export.
28 September 2026 · Capital News →
The Pharmacy and Poisons Board has issued a public alert over falsified batches of Lucentis (Ranibizumab) 0.3mg injection circulating in Kenya, detected through post-marketing surveillance, with one person arrested in possession of the product. The fake product carries batch numbers 18862110 and 18802112 and falsely claims manufacture by Genentech, differing from the genuine Novartis product in labelling, dosage specification, and vial colour.
28 September 2026 · Citizen Digital →
A five-year project in Kenya is testing whether selected community pharmacies can provide contraceptive counselling, method choice and reproductive health services alongside dispensing, aiming to bridge the gap between simple commodity sales and quality family planning care. The Strengthening Pharmacy Provision of Contraceptives in Kenya Market Test project, implemented by inSupply Health with the Ministry of Health and partner organisations, began in 2021 to assess whether the expanded model works for both clients and businesses.
28 September 2026 · The Standard →
An opinion piece argues that pharmacy practice in Kenya has evolved beyond medicine dispensing to include patient counseling, disease management, and preventive care, requiring structures like Good Pharmacy Practice standards to ensure pharmacists meet the highest care standards.
25 September 2026 · The Standard →
The Anti-Counterfeit Authority reports that Kenya loses more than Sh153 billion annually to counterfeit trade in health, agriculture, electronics, and automotive sectors. The article notes that illicit trade is becoming normalised in everyday economic life, as consumers knowingly or unknowingly purchase counterfeit goods.
22 September 2026 · The Standard →
Taxpayers face losses of approximately Sh1 billion in expired medicines, prompting the Senate Health Committee to demand answers from the Pharmacy and Poisons Board over management, inspection and disposal gaps. A KEMSA report revealed that expired stock included drugs for cancer, HIV and malaria treatment, raising questions about weak inspection capacity, poor stock management and distribution delays.
18 September 2026 · Capital News →
The Pharmacy and Poisons Board has unveiled Good Pharmacy Practice (GPP) Standards at the Kenya Health Summit, setting expectations for pharmaceutical care. The piece argues that while individual provisions may require refinement, the standards represent progress toward fulfilling Kenyans' constitutional right to the highest attainable standard of health.
17 September 2026 · The Standard →
The Kenya Pharmaceutical Association and Kenya National Union of Pharmaceutical Technologists have threatened strike action over new Pharmacy and Poisons Board guidelines that restrict pharmacists without degree-level qualifications from practising in Level 3 and 4 health facilities. The associations say the rules are discriminatory and could damage healthcare operations as pharmacists constitute over 70 per cent of all healthcare practitioners.
7 September 2026 · The Standard →
The Pharmacy and Poisons Board has called for stronger quality assurance, safety monitoring and scientific research to ensure traditional medicines used in Kenya are safe, effective and of consistent quality, emphasizing accurate dosing, standardised production and clear product labelling.
6 September 2026 · The Standard →
The Ministry of Health has defended the 2026 Good Pharmacy Practice Standards following demonstrations by diploma-holding pharmacy professionals. Health Cabinet Secretary Aden Duale stated that the standards distinguish between pharmacy professionals and facility superintendents, and do not bar diploma or degree holders from practising provided they are duly registered, enrolled, and licensed within their respective legal scope.
4 September 2026 · Citizen Digital →
Kenya's medical research and disease surveillance is expected to improve through increased access to dry ice and specialised cold-chain services, which are critical for keeping biological samples at required temperatures during collection and transportation to laboratories. KEMRI notes that gaps in cold-chain facilities outside Nairobi can compromise sample integrity, particularly during disease outbreaks and for regional diagnostics work.
31 August 2026 · The Standard →
The Pharmacy and Poisons Board is strengthening oversight of storage, transportation and distribution of medicines through nationwide inspections of hospitals, retail pharmacies, wholesalers and transporters. During 2025/2026, PPB conducted 3,453 compliance inspections with an 82.4 per cent compliance rate, and the board says sustained oversight beyond manufacturing is necessary to ensure patients receive safe, quality products.
31 August 2026 · The Standard →
Kenya has attracted 13 new pharmaceutical manufacturers at various stages of establishment and operationalisation, strengthening the country's efforts to expand local production of medicines and health products. The Pharmacy and Poisons Board is providing regulatory guidance and technical support to ensure locally manufactured products meet quality, safety and efficacy standards.
27 August 2026 · The Standard →
An opinion piece warns that foreign researchers are extracting health data from low-income Kenyan communities to train AI medical devices that generate significant profits, with little or no benefit returning to the data sources. The author argues Kenya must secure ownership of its health data before such exploitation becomes entrenched.
26 August 2026 · The Standard →
The Pharmacy and Poisons Board says it has strengthened regulation of pharmacy practice and health products as part of reforms to protect patients and support Universal Health Coverage, including licensing of 15,679 pharmaceutical professionals and 11,141 premises, introducing Kenya's first Good Pharmacy Practice Standards, and digitising regulatory services.
21 August 2026 · Citizen Digital →
Deputy President Kindiki says the government is stepping up efforts to register all Kenyans under the Social Health Authority's Taifa Care programme, targeting 40 million enrollments by year-end after registering 32 million over the last two years, with a goal of universal registration by August next year.
19 August 2026 · Citizen Digital →
Deputy President Kindiki says the government aims to register 40 million Kenyans under the Social Health Authority (SHA) by the end of 2024, up from 32 million over the past two years, with a goal of universal coverage by August 2027.
19 August 2026 · Capital News →
A video circulating on social media has prompted questions about the authenticity and regulatory compliance of personal-care products on retail shelves, including items labelled Clodigte and Senodcseoly, though there is currently no independent verification that the products are counterfeit or substandard.
19 August 2026 · Citizen Digital →
The Pharmacy and Poisons Board has issued alerts about counterfeit Postinor-2 emergency contraceptives circulating in Kenya's market, part of a broader problem of sub-standard, expired, and fake medicines in hospital and pharmacy stores. The opinion argues that regulatory enforcement, port health authorities, and customs control mechanisms have failed in oversight, allowing counterfeit drugs to reach local chemists.
17 August 2026 · The Standard →
Kenya is implementing a medicine tracking system to combat counterfeit drugs. The Pharmacy and Poisons Board is leading efforts to tighten control over pharmaceuticals in the market.
17 August 2026 · The Standard →
The Pharmacy and Poisons Board has approved seven semaglutide-based medicines in Kenya, expanding treatment options for type 2 diabetes. Although the products share the same active ingredient, they do not necessarily have the same approved uses, and the regulator has warned the public against using semaglutide medicines without medical supervision, particularly for weight loss.
15 August 2026 · Citizen Digital →
The Pharmacy and Poisons Board has alerted the public to falsified Postinor-2 emergency contraceptive pills circulating in Kenya, warning that the counterfeits may contain incorrect or no active ingredient, harmful contaminants, or undeclared substances, potentially failing to prevent unintended pregnancies. The affected batch is Postinor-2, Batch No. T34197R, falsely claimed to be manufactured by Gedeon Richter, and can be distinguished from genuine products by printing differences, carton-sealing methods, and altered logo fonts on the authentication panel.
15 August 2026 · The Standard →
The Pharmacy and Poisons Board has warned of a falsified batch of Postinor-2 (emergency contraceptive) pills circulating in Kenya, identified as Batch Number T34197R. The counterfeit product differs from genuine pills in batch printing method, carton sealing, and patient information leaflet quality.
14 August 2026 · Citizen Digital →
The Pharmacy and Poisons Board has alerted the public to a fake batch of Postinor-2 (Levonorgestrel 0.75mg), batch number T34197R, falsely claiming manufacture by Gedeon Richter Plc. The counterfeit product differs from genuine stock in packaging, sealing, and printing methods, and may contain incorrect or no active ingredient, harmful contaminants, or undeclared substances.
14 August 2026 · The Standard →
The article argues that medicines regulation is essential to public health, ensuring patients receive safe, effective, and quality products through evaluation, manufacturing standards, secure supply chains, and post-market monitoring, particularly as Kenya advances Universal Health Coverage.
16 July 2026 · Citizen Digital →
An opinion piece argues that safe, effective medical products depend on rigorous regulatory processes—evaluation before market entry, manufacturing standards, secure supply chains, and post-market monitoring—which are essential as Kenya advances Universal Health Coverage.
16 July 2026 · Citizen Digital →
Health Cabinet Secretary Aden Duale announced plans to ban the delivery of antibiotics through boda boda riders as part of efforts to combat counterfeit medicines and illegal online sales of prescription drugs, stating that prescription drugs should only be dispensed through licensed pharmacies.
3 July 2026 · Citizen Digital →